Unimedic Pharma launches Melatonin Oral Solution – prescription-free option for adults experiencing jet lag
Senaste nyheterna
Utvalda nyheter
Utvalda nyheter
Unimedic Pharma launches Melatonin Oral Solution – prescription-free option for adults experiencing jet lag
-
Unimedic Pharma lanserar Melatonin oral lösning – receptfritt alternativ för vuxna vid jetlag
Unimedic Pharma lanserar Melatonin oral lösning – receptfritt alternativ för vuxna vid jetlag. Produkten erbjuder flexibel dosering som kan anpassas efter individuella behov och är särskilt lämplig för personer som har svårt att svälja tabletter. Den lilla flaskan gör den enkel att ta med på resor över flera tidszoner. Säljs på apotek fr.o.m. vecka 41.
-
Unimedic Pharma acquires XGX Pharma
Unimedic Pharma AB has now completed the acquisition of XGX Pharma ApS (“XGX”) in Denmark.
XGX is a fast-growing specialty pharma company with a pipeline of new products. Currently, XGX has eight products on the market, primarily in the Nordics. The pipeline consists of niche products either in late-stage development or registration phase.
Johan Frödin, CEO of Unimedic Group, comments the a -
Melatonin Unimedic Pharma 1 mg/ml drink for children with ADHD and insomnia now available in the Belgian market
Unimedic Pharma AB, in partnership with its distributor TwinPharma BV, has launched Melatonin Unimedic Pharma 1 mg/ml drink in Belgium.
Johan Frödin, CEO of Unimedic Pharma says: "This marks a significant step for children with ADHD and insomnia. Our commitment to innovation and patient care drives us to develop solutions that address unmet medical needs, and we are very proud to offer this tre -
Unimedic Pharma AB announces distribution and launch of Zeqmelit® orodispersible film (dexametason) in Sweden, Norway, and Finland
Stockholm, September 17th, 2024 – Unimedic Pharma AB has according to plan started the distribution and launch of Zeqmelit® orodispersible film (dexametason) in Sweden, Norway, and Finland.
As Nordic partner to AcuCort, Unimedic Pharma carry the responsibility for marketing, distribution, and sales of the prescription drug Zeqmelit® (dexametason) in the Nordic region. From September, Zeqmelit® -
Unimedic Pharma AB out-license Melatonin oral solution in Belgium to TwinPharma BV
Unimedic Pharma AB has signed a distribution agreement with TwinPharma BV for the launch of Melatonin 1 mg/ml oral solution in Belgium.
Unimedic Pharma and TwinPharma entered into a supply and distribution agreement in 2017 and the addition of Melatonin 1mg/ml is the third product in the collaboration.
In this partnership, TwinPharma is appointed exclusive distributor of Melatonin Unimedi -
Unimedic Pharma AB announces new distribution agreement with AcuCort for Zeqmelit® oral film (dexametason) in Sweden, Denmark, Norway, and Finland
Stockholm, August 31st, 2023 – Unimedic Pharma AB announced today that Unimedic Pharma has entered into a license and distribution agreement with AcuCort AB for AcuCort’s Zeqmelit® oral film (dexametason) in Sweden, Denmark, Norway, and Finland.
-
Unimedic Pharma AB enter a collaboration with Consilient Health Limited for the launch of Melatonin oral solution in the UK
Unimedic Pharma AB have signed a license and supply agreement with Consilient Health for the launch of Melatonin 1 mg/ml oral solution in the UK. On November 16, 2021 the Medicines and Healthcare products Regulatory Agency (MHRA) granted Melatonin Consilient Health approval for insomnia in children with ADHD, as well as for short-term jet-lag therapy in adults
Kontakter
-
Johan Frödin Presskontakt CEO johan.frodin@unimedic.se +46 (0)70 878 72 80
